BRA Day is an initiative designed to promote education, awareness and access for women who may wish to consider post-mastectomy breast reconstruction.
Anaplastic Large Cell Lymphoma (ALCL)
In January 2011, the American Food and Drug Administration (FDA) issued a communication to inform health care providers and the public about a possible association between breast implants and a type of anaplastic large cell lymphoma (ALCL).
Information published by the FDA is available in the following web pages:
Further information from the Canadian Society of Plastic Surgeons:
ALCL Letter to CSPS Membership (August 12, 2019)
ALCL Letter to CSPS Membership (July 30, 2019)
ALCL Letter to CSPS Membership (May 30, 2019)